The healthcare industry is transitioning from a fee-for-service payment model to a value-based purchasing model. To thrive in this transformative age, medtechs must build / adapt their business models to meet the increased expectations of consumers and other healthcare stakeholders. Is value the holy grail for every company? Definitely it is something executives, investors and researchers are interested in since decades
Social innovation opens up for new ways of creating value, solving problems – and doing business. Social innovation will be an increasingly crucial competitive advantage as MedTech startups look to innovation to tackle the big social challenges that affect us such as our ageing population or public health issues.
The MedTech industry has grown significantly in Asia Pacific. Innovations brought about by this growth pose a series of challenges for regulators. As MedTech startups continue to create value, can MedTech innovation be compliant? XXX will discuss the emergence and impact of regulatory sandboxes in MedTech.
Intellectual Property (IP) has always been paramount to any innovative MedTech company’s success. Having a concrete understanding of your product value can help you secure a strong valuation or the financing you need. Securing IP protection immediately communicates the value-add to investors.
Reimbursement mechanisms are vital to the MedTech industry but many start-ups are still figuring out how to navigate this complex system. Understanding the reimbursement landscape across the diverse APAC region will help to inform innovative business strategies and may play an important role in fostering attractiveness to investors.
MedTech startups have to convince investors that their innovations are worth their investment. It is a delicate dance to find the right potential investor with a tolerance for the risk and the long-term horizon to profitability while also requiring deep pockets for product development. How can we find aligned startup investors at each stages of development – from seed stage to startup stage and expansion stage?
The world's leading enterprises are now playing an important role in driving external innovation to help entrepreneurs turn ideas into products. Do startup-corporate partnerships offer the greatest opportunity for corporate innovation? Let’s hear it from Johnson & Johnson, who is investing in, building, and partnering with technology companies to improve lives.
Are physicians better than technology investors, who might not have a sense of many complexities and nuances in the healthcare sector? Clinical investors don’t buy with the hear, they buy with their head. We hear from Dr. Tan on how clinical leaders and contribute to shape health innovation.
A new era of digital innovation in medical devices are driving growth in global medical devices industry to US$500 billion in 2018, with APAC leading the growth. Virginia will share with us how medical devices and digital health start-ups in APAC can accelerate time-to-market and global market expansion with digital innovation, smart regulatory compliance and smart manufacturing.
Innovation is key to sustainable success, and startups, corporates and care providers are coming together to accelerate innovation. This is a hybrid model in which startups, corporates and care providers are needed to come up with new solutions to advance care. How can startups, corporates and care providers partner for success?